Monovisc 88 MG/4 ML syringe 4ML
Ended Awarded
- Contract number
- SPE2DB25FU9KS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,222
Award facts
- Contract value 100% obligated
- $1,221.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,221.75 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 ml syringes (4 ml quantity) on June 18, 2025, with an ultimate completion date of June 20, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Monovisc is a viscosupplement injection used to treat osteoarthritis pain, representing a specialized pharmaceutical product within the broader medical supply portfolio that DLA procures to support military healthcare systems.
This delivery order was issued under AmerisourceBergen Drug Corp's existing indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies an extensive range of medications, vaccines, medical devices, and healthcare commodities to support Defense Health Agency operations and other government healthcare systems globally. The company's federal contracting history demonstrates consistent capability to meet competitive procurement requirements across multiple therapeutic domains and transaction sizes.
Quick answers
Who was awarded contract SPE2DB25FU9KS?
SPE2DB25FU9KS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FU9KS worth?
The government has obligated $1,222 on SPE2DB25FU9KS.
Is contract SPE2DB25FU9KS an order under another contract?
Yes. SPE2DB25FU9KS is a delivery order under SPE2DB22D1052, an indefinite delivery contract.
Was contract SPE2DB25FU9KS competed?
The extent of competition for SPE2DB25FU9KS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award